Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 5
1965 34
1966 64
1967 60
1968 101
1969 288
1970 302
1971 416
1972 445
1973 486
1974 478
1975 404
1976 380
1977 326
1978 313
1979 322
1980 333
1981 311
1982 339
1983 372
1984 372
1985 370
1986 382
1987 404
1988 361
1989 421
1990 411
1991 416
1992 429
1993 424
1994 469
1995 491
1996 518
1997 484
1998 554
1999 559
2000 552
2001 563
2002 581
2003 626
2004 644
2005 695
2006 785
2007 741
2008 859
2009 804
2010 888
2011 1016
2012 1034
2013 1136
2014 1093
2015 1149
2016 1256
2017 1250
2018 1277
2019 1292
2020 1378
2021 140
Text availability
Article attribute
Article type
Publication date

Search Results

30,826 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacokinetic interactions with rifampicin : clinical relevance.
Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivistö KT. Niemi M, et al. Clin Pharmacokinet. 2003;42(9):819-50. doi: 10.2165/00003088-200342090-00003. Clin Pharmacokinet. 2003. PMID: 12882588 Review.
The antituberculosis drug rifampicin (rifampin) induces a number of drug-metabolising enzymes, having the greatest effects on the expression of cytochrome P450 (CYP) 3A4 in the liver and in the small intestine. ...Rifampicin also induces CYP2C-mediated metabo …
The antituberculosis drug rifampicin (rifampin) induces a number of drug-metabolising enzymes, having the greatest effects on …
Rifapentine.
Jarvis B, Lamb HM. Jarvis B, et al. Drugs. 1998 Oct;56(4):607-16; discussion 617. doi: 10.2165/00003495-199856040-00008. Drugs. 1998. PMID: 9806107 Review.
Rifapentine is generally more active against Mycobacterium tuberculosis than rifampicin (rifampin), although strains resistant to rifampicin are usually cross-resistant to rifapentine. ...In one trial, there was no difference in sputum culture conversion rate …
Rifapentine is generally more active against Mycobacterium tuberculosis than rifampicin (rifampin), although strains resistant …
Rifapentine.
[No authors listed] [No authors listed] Tuberculosis (Edinb). 2008 Mar;88(2):155-8. doi: 10.1016/S1472-9792(08)70025-8. Tuberculosis (Edinb). 2008. PMID: 18486059 Review. No abstract available.
Rifampicin.
[No authors listed] [No authors listed] IARC Monogr Eval Carcinog Risk Chem Hum. 1980;24:243-58. IARC Monogr Eval Carcinog Risk Chem Hum. 1980. PMID: 7009395 Review. No abstract available.
Rifampin.
Farr B, Mandell GL. Farr B, et al. Med Clin North Am. 1982 Jan;66(1):157-68. doi: 10.1016/s0025-7125(16)31449-3. Med Clin North Am. 1982. PMID: 7038325 Review. No abstract available.
Rifampicin.
[No authors listed] [No authors listed] Drug Ther Bull. 1970 Jan 30;8(3):11-2. Drug Ther Bull. 1970. PMID: 5417897 No abstract available.
Rifampicin.
Murdoch JM, Speirs CF, Wright N, Wallace ET. Murdoch JM, et al. Lancet. 1969 May 31;1(7605):1094. doi: 10.1016/s0140-6736(69)91725-5. Lancet. 1969. PMID: 4181749 No abstract available.
An ultra-sensitive "turn-off" fluorescent sensor for the trace detection of rifampicin based on glutathione-stabilized copper nanoclusters.
Wu XM , Zhang JH , Feng ZS , Chen WX , Zhang F , Li Y . Wu XM , et al. Analyst. 2020 Feb 17;145(4):1227-1235. doi: 10.1039/c9an01994d. Analyst. 2020. PMID: 31898707
Rifampicin is a common antibiotic used in human and veterinary medicine to treat tuberculosis and other diseases caused by numerous pathogenic bacteria. ...Thus, it is of great importance to develop selective and sensitive assays for monitoring rifampicin in biologi
Rifampicin is a common antibiotic used in human and veterinary medicine to treat tuberculosis and other diseases caused by numerous p
[The "second life" of rifampicin].
Stettler R, Trampuz A. Stettler R, et al. Rev Med Suisse. 2014 Mar 19;10(422):670-2. Rev Med Suisse. 2014. PMID: 24734367 Review. French.
Rifampicin has an excellent tissue penetration and a unique activity on bacteria in biofilms growing on the surface of prosthetic devices. The rapid emergence of resistance in bacteria constitutes the Achilles' heel and therefore rifampicin should be used with cauti
Rifampicin has an excellent tissue penetration and a unique activity on bacteria in biofilms growing on the surface of prosthetic dev
[Rifampicin].
Simon F, Bohand X. Simon F, et al. Med Trop (Mars). 1998;58(3):229-30. Med Trop (Mars). 1998. PMID: 10088095 French. No abstract available.
30,826 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page